Clinical trials
Thromboembolism trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 7 |
| Bayer | 5 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
| Janssen Research & Development, LLC | 2 |
| Abbott Medical Devices | 1 |
| Astellas Pharma Inc | 1 |
| AstraZeneca | 1 |
| Boston Scientific Corporation | 1 |
| Daiichi Sankyo | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thromboembolism | 28 |
| Thrombosis | 6 |
| Atrial Fibrillation | 5 |
| Stroke | 5 |
| Venous Thromboembolism | 5 |
| Pulmonary Embolism | 4 |
| Venous Thrombosis | 4 |
| Ischemic Attack, Transient | 2 |
| Breast Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
Trials
Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.